(Q31397850)

2 July 2017

title

Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial (English)

1 reference

2 July 2017

0 references

1 reference

T P George

1

1 reference

2 July 2017

M C Chawarski

2

1 reference

2 July 2017

J Pakes

3

1 reference

2 July 2017

K M Carroll

4

1 reference

2 July 2017

T R Kosten

5

1 reference

2 July 2017

R S Schottenfeld

6

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

2 July 2017

published in

Biological Psychiatry

1 reference

2 July 2017

volume

47

1 reference

2 July 2017

issue

12

1 reference

2 July 2017

page(s)

1080-1086

1 reference

Comparative effects of two dithiocarbamates disulfiram and thiram, on adrenal catecholamine content and on plasma dopamine-beta-hydroxylase activity

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Pharmacologic Interventions for Alcohol- and Cocaine-Abusing Individuals: A Pilot Study of Disulfiram vs. Naltrexone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine as a pharmacotherapy for cocaine abuse: a review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

INHIBITION OF DOPAMINE-BETA-HYDROXYLASE BY DISULFIRAM

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Inhibition of drug demethylation by disulfiram in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Treatment of cocaine abuse with buprenorphine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Chronic disulfiram treatment effects on intranasal cocaine administration: initial results.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Disulfiram effects on acute cocaine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

HIV infection and cocaine use in methadone maintained and untreated intravenous drug users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine suppresses cocaine self-administration by rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine: dose-related effects on cocaine and opioid use in cocaine-abusing opioid-dependent humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

Disulfiram therapy in patients abusing cocaine and alcohol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900310-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00310-8

1 reference

2 July 2017

1 reference